Triple-negative Breast Cancer: a New Perspective on Biomarkers

Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

NCT04145947 ·Status: UNKNOWN

Microbiome Immunotherapy Neoadjuvant Assessment

NCT06709651 ·Status: RECRUITING

Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer

NCT06418126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Comparison of the Breast Tumor Microenvironment

NCT03165487 ·Status: ACTIVE_NOT_RECRUITING

Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer

NCT06879704 ·Status: RECRUITING ·Phase: NA

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

NCT05528133 ·Status: RECRUITING ·Phase: PHASE2

Prospective Evaluation of Breast Cancer at Brazilian Institutions - Project AMAZONA III

NCT02663973 ·Status: COMPLETED

Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

NCT04365790 ·Status: UNKNOWN

Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer

NCT05914961 ·Status: RECRUITING

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

NCT05877859 ·Status: RECRUITING

VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study

NCT06409221 ·Status: ENROLLING_BY_INVITATION

Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging

NCT05809128 ·Status: UNKNOWN

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm

NCT02266420 ·Status: COMPLETED ·Phase: NA

Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

NCT01276899 ·Status: COMPLETED

Gut and Intratumoral Microbiome Effect on the Neoadjuvant Chemotherapy-induced Immunosurveillance in Triple Negative Breast Cancer

NCT03586297 ·Status: COMPLETED

Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome

NCT06261918 ·Status: RECRUITING

Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)

NCT02688803 ·Status: TERMINATED ·Phase: PHASE4

Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy

NCT03556397 ·Status: COMPLETED ·Phase: NA

Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer

NCT04021069 ·Status: UNKNOWN

BRCA and NACT in TNBC Patients

NCT05750719 ·Status: COMPLETED

Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil

NCT05034393 ·Status: COMPLETED

Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes

NCT04403984 ·Status: UNKNOWN

Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine

NCT06102018 ·Status: RECRUITING

Using of Costimulatory and co Inhibatory Immune Checkpoints as Diagnostic and Prognostic in Breast Cancer

NCT06169007 ·Status: NOT_YET_RECRUITING

Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT03381092 ·Status: UNKNOWN